Cresco Labs (CRLBF) EBITDA Margin (2020 - 2026)
Cresco Labs (CRLBF) reported EBITDA Margin of 11.38% for Q1 2026, down 219.0% on a YoY basis from 9.56% in Q1 2025, and up 79.29% quarter-over-quarter from 54.94% in Q4 2025.
Cresco Labs (CRLBF) EBITDA Margin (2020 - 2026) Analysis & Trends
Cresco Labs has reported EBITDA Margin for 7 years, with the latest figure at 11.38% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 219.0% year-over-year to 11.38%; the trailing twelve-month figure through Mar 2026 stood at 22.05% (down 953.0% YoY), and the FY2025 full-year result was 21.26%, down 1084.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 11.38%, up from 54.94% in the prior quarter.
- The five-year high for EBITDA Margin was 14.4% in Q4 2023, with the low at 71.89% in Q4 2022.
- Historically, EBITDA Margin has averaged 13.45% across 5 years, with a median of 8.11% in 2025.
- The largest YoY upside for EBITDA Margin was 13024 bps in 2022 against a maximum downside of 7903 bps in 2022.
- Cresco Labs' EBITDA Margin stood at 71.89% in 2022, then jumped by 120 bps to 14.4% in 2023, then plunged by 157 bps to 8.14% in 2024, then sank by 575 bps to 54.94% in 2025, then surged by 79 bps to 11.38% in 2026.
- The last three EBITDA Margin figures came in at 11.38% (Q1 2026), 54.94% (Q4 2025), and 13.46% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -170.35% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -16.25% |
| 10 | Cresco Labs | - | - | 75.45 Mn | -11.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.38% |
| Dec 31, 2025 | -54.94% |
| Sep 30, 2025 | -13.46% |
| Jun 30, 2025 | -8.11% |
| Mar 31, 2025 | -9.18% |
| Dec 31, 2024 | -8.14% |
| Sep 30, 2024 | -4.19% |
| Jun 30, 2024 | -27.83% |
| Mar 31, 2024 | -1.28% |
| Dec 31, 2023 | 14.40% |
| Sep 30, 2023 | -56.55% |
| Jun 30, 2023 | -5.43% |
| Mar 31, 2023 | 1.85% |
| Dec 31, 2022 | -71.89% |
| Sep 30, 2022 | 7.72% |
| Jun 30, 2022 | 10.39% |
| Mar 31, 2022 | 9.45% |
| Dec 31, 2021 | 7.14% |
| Sep 30, 2021 | -122.52% |
| Jun 30, 2021 | 7.08% |